Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Karl-Erik Andersson, M.D., Ph.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentWF Institute for Regen Medicine
AddressA1A
Medical Center Blvd
Phone336-713-1195
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentPhysiology and Pharmacology

    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentSurgical Sciences-Urology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y. Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction. Sci Rep. 2017 Aug 09; 7(1):7646. PMID: 28794457.
      View in: PubMed
    2. Ichihara K, Aizawa N, Akiyama Y, Kamei J, Masumori N, Andersson KE, Homma Y, Igawa Y. Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain. Pain. 2017 Aug; 158(8):1538-1545. PMID: 28595240.
      View in: PubMed
    3. Koudy Williams J, Dean A, Lankford S, Andersson KE. Efficacy and Initial Safety Profile of CXCL12 Treatment in a Rodent Model of Urinary Sphincter Deficiency. Stem Cells Transl Med. 2017 Aug; 6(8):1740-1746. PMID: 28714578.
      View in: PubMed
    4. Cao N, Ni J, Wang X, Tu H, Gu B, Si J, Wu G, Andersson KE. Chronic spinal cord injury causes upregulation of serotonin (5-HT)2A and 5-HT2C receptors in lumbosacral cord motoneurons. BJU Int. 2017 Jul 15. PMID: 28710888.
      View in: PubMed
    5. Andersson KE. Pharmacology: Cardiovascular effects of mirabegron. Nat Rev Urol. 2017 Jul 11. PMID: 28695920.
      View in: PubMed
    6. Andersson KE. Re: Inhibition of Cholinergic Neurotransmission by ß3-adrenoceptors Depends on Adenosine Release and A1 Receptors Activation in Human and Rat Urinary Bladders. Eur Urol. 2017 Oct; 72(4):650-651. PMID: 28601353.
      View in: PubMed
    7. Andersson KE. Drugs for the overactive bladder: are there differences in persistence and compliance? Transl Androl Urol. 2017 Jun; 6(3):597-601. PMID: 28725606.
      View in: PubMed
    8. Mann-Gow TK, Larson TR, Wøien CT, Andersen TM, Andersson KE, Zvara P. Evaluating the Procedure for Performing Awake Cystometry in a Mouse Model. J Vis Exp. 2017 May 20; (123). PMID: 28570547.
      View in: PubMed
    9. Zarifpour M, Andersson KE, Kelkar SS, Mohs A, Mendelsohn C, Schneider K, Marini F, Christ GJ. Characterization of a Murine Model of Bioequivalent Bladder Wound Healing and Repair Following Subtotal Cystectomy. Biores Open Access. 2017; 6(1):35-45. PMID: 28560089.
      View in: PubMed
    10. Vahabi B, Wagg AS, Rosier PFWM, Rademakers KLJ, Denys MA, Pontari M, Lovick T, Valentini FA, Nelson PP, Andersson KE, Fry CH. Can we define and characterize the aging lower urinary tract?-ICI-RS 2015. Neurourol Urodyn. 2017 Apr; 36(4):854-858. PMID: 28444710.
      View in: PubMed
    11. Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso K, Deshpande S, Kleijnen J, Milsom I. Can incontinence be cured? A systematic review of cure rates. BMC Med. 2017 Mar 24; 15(1):63. PMID: 28335792.
      View in: PubMed
    12. Andersson KE. On the Site and Mechanism of Action of ß3-Adrenoceptor Agonists in the Bladder. Int Neurourol J. 2017 Mar 24; 21(1):6-11. PMID: 28361520.
      View in: PubMed
    13. Glindtvad C, Chen M, Vinge Nygaard J, Wogensen L, Forman A, Danielsen CC, Taskin MB, Andersson KE, Axelsen SM. Electrospun biodegradable microfibers induce new collagen formation in a rat abdominal wall defect model: A possible treatment for pelvic floor repair? J Biomed Mater Res B Appl Biomater. 2017 Mar 17. PMID: 28306194.
      View in: PubMed
    14. Lin WY, Andersson KE, Lin CL, Kao CH, Wu HC. Association of lower urinary tract syndrome with peripheral arterial occlusive disease. PLoS One. 2017; 12(3):e0170288. PMID: 28301517.
      View in: PubMed
    15. Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2017 Feb 12. PMID: 28202356.
      View in: PubMed
    16. Andersson KE, Williams JK. Regenerative pharmacology in urology. Investig Clin Urol. 2017 Mar; 58(2):79-81. PMID: 28261675.
      View in: PubMed
    17. Ihara T, Mitsui T, Nakamura Y, Kira S, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. Clock Genes Regulate the Circadian Expression of Piezo1, TRPV4, Connexin26, and VNUT in an Ex Vivo Mouse Bladder Mucosa. PLoS One. 2017; 12(1):e0168234. PMID: 28060940.
      View in: PubMed
    18. Williams JK, Dean A, Lankford S, Criswell T, Badlani G, Andersson KE. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2017 Jan 06; 8(1):1. PMID: 28057078.
      View in: PubMed
    19. Williams JK, Andersson KE. Regenerative pharmacology: recent developments and future perspectives. Regen Med. 2016 Dec; 11(8):859-870. PMID: 27905259.
      View in: PubMed
    20. Kallner HK, Elmér C, Andersson KE, Altman D. Hormonal influence on the effect of mirabegron treatment for overactive bladder. Menopause. 2016 Dec; 23(12):1303-1306. PMID: 27529461.
      View in: PubMed
    21. Andersson KE, Boedtkjer DB, Forman A. The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction. Ther Adv Urol. 2017 Jan; 9(1):11-27. PMID: 28042309.
      View in: PubMed
    22. Williams JK, Badlani G, Dean A, Lankford S, Poppante K, Criswell T, Andersson KE. Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2016 Oct 07; 7(1):147. PMID: 27717380.
      View in: PubMed
    23. Simonsen U, Comerma-Steffensen S, Andersson KE. Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:63-74. PMID: 27541930.
      View in: PubMed
    24. Andersson KE. Re: Nonantimuscarinic Treatment for Overactive Bladder: A Systematic Review. Eur Urol. 2016 Dec; 70(6):1077. PMID: 27568656.
      View in: PubMed
    25. Williams JK, Dean A, Badlani G, Andersson KE. Regenerative Medicine Therapies for Stress Urinary Incontinence. J Urol. 2016 Dec; 196(6):1619-1626. PMID: 27544623.
      View in: PubMed
    26. Ihara T, Mitsui T, Nakamura Y, Kira S, Miyamoto T, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. The Clock mutant mouse is a novel experimental model for nocturia and nocturnal polyuria. Neurourol Urodyn. 2017 Apr; 36(4):1034-1038. PMID: 27348079.
      View in: PubMed
    27. Williams JK, Dean A, Badra S, Lankford S, Poppante K, Badlani G, Andersson KE. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. J Urol. 2016 Dec; 196(6):1809-1815. PMID: 27267321.
      View in: PubMed
    28. Ito H, Kamei J, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Fujimura T, Kojima T, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia in Rats. J Urol. 2016 Nov; 196(5):1575-1583. PMID: 27259654.
      View in: PubMed
    29. Andersson KE. Potential Future Pharmacological Treatment of Bladder Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:75-85. PMID: 26990140.
      View in: PubMed
    30. Abdel-Hamid IA, Andersson KE, Waldinger MD, Anis TH. Tramadol Abuse and Sexual Function. Sex Med Rev. 2016 Jul; 4(3):235-246. PMID: 27871957.
      View in: PubMed
    31. Kirschner-Hermanns R, Anding R, Rosier P, Birder L, Andersson KE, Djurhuus JC. Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014. Neurourol Urodyn. 2016 Feb; 35(2):318-23. PMID: 26872575; PMCID: PMC4760427.
    32. Broegger T, Andersson KE, Aalkjaer C, Forman A, Boedtkjer DB. Sensitivity to the thromboxane A2 analog U46619 varies with inner diameter in human stem villous arteries. Placenta. 2016 Mar; 39:111-5. PMID: 26992683.
      View in: PubMed
    33. Sawada N, Nomiya M, Zarifpour M, Mitsui T, Takeda M, Andersson KE. Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia. J Sex Med. 2016 Feb; 13(2):179-86. PMID: 26803454.
      View in: PubMed
    34. Peng Z, Andersson K, Lindholm J, Dethlefsen O, Pramana S, Pawitan Y, Nistér M, Nilsson S, Li C. Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material. PLoS One. 2016; 11(1):e0145545. PMID: 26731648; PMCID: PMC4701463.
    35. Andersson KE. Pharmacology: On the mode of action of mirabegron. Nat Rev Urol. 2016 Mar; 13(3):131-2. PMID: 26666361.
      View in: PubMed
    36. Burmeister D, Bishwokarma B, AbouShwareb T, Olson J, Herco M, Tan J, Andersson KE, Christ G. The potential utility of non-invasive imaging to monitor restoration of bladder structure and function following subtotal cystectomy (STC). BMC Urol. 2015 Oct 14; 15:103. PMID: 26463481; PMCID: PMC4604729.
    37. Andersson KE. Drug therapy of overactive bladder--what is coming next? Korean J Urol. 2015 Oct; 56(10):673-9. PMID: 26495067; PMCID: PMC4610893.
    38. Ito H, Aizawa N, Sugiyama R, Watanabe S, Takahashi N, Tajimi M, Fukuhara H, Homma Y, Kubota Y, Andersson KE, Igawa Y. Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in the urinary bladder assessed by conscious cystometry and ex vivo measurements of single-unit mechanosensitive bladder afferent activities in the rat. BJU Int. 2016 Mar; 117(3):484-94. PMID: 26189966.
      View in: PubMed
    39. Kullmann FA, Birder LA, Andersson KE. Translational Research and Functional Changes in Voiding Function in Older Adults. Clin Geriatr Med. 2015 Nov; 31(4):535-48. PMID: 26476114; PMCID: PMC4865381.
    40. Andersson KE. Mechanisms of ATP release--future therapeutic targets? BJU Int. 2015 Jun; 115(6):850-1. PMID: 25382695.
      View in: PubMed
    41. Tu H, Cao N, Gu B, Si J, Chen Z, Andersson KE. Serotonin (5-HT)2A/2C receptor agonist (2,5-dimethoxy-4-idophenyl)-2-aminopropane hydrochloride (DOI) improves voiding efficiency in the diabetic rat. BJU Int. 2015 Jul; 116(1):147-55. PMID: 25822577.
      View in: PubMed
    42. Peess C, von Proff L, Goller S, Andersson K, Gerg M, Malmqvist M, Bossenmaier B, Schräml M. Deciphering the stepwise binding mode of HRG1ß to HER3 by surface plasmon resonance and interaction map. PLoS One. 2015; 10(2):e0116870. PMID: 25658697; PMCID: PMC4319926.
    43. Salemi S, Tremp M, Plock JA, Andersson KE, Gobet R, Sulser T, Eberli D. Differentiated adipose-derived stem cells for bladder bioengineering. Scand J Urol. 2015; 49(5):407-14. PMID: 25652651.
      View in: PubMed
    44. Andersson KE. Intraprostatic injections for lower urinary tract symptoms treatment. Curr Opin Urol. 2015 Jan; 25(1):12-8. PMID: 25333915.
      View in: PubMed
    45. Guimarães-Souza NK, Yamaleyeva LM, Lu B, Ramos AC, Bishop CE, Andersson KE. Superoxide overproduction and kidney fibrosis: a new animal model. Einstein (Sao Paulo). 2015 Jan-Mar; 13(1):79-88. PMID: 25993073; PMCID: PMC4977594.
    46. Andersson KE, Nomiya M, Yamaguchi O. Chronic Pelvic Ischemia: Contribution to the Pathogenesis of Lower Urinary Tract Symptoms (LUTS): A New Target for Pharmacological Treatment? Low Urin Tract Symptoms. 2015 Jan; 7(1):1-8. PMID: 26663644.
      View in: PubMed
    47. Ito H, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Long-term caloric restriction in rats may prevent age related impairment of in vitro bladder function. J Urol. 2015 Jun; 193(6):2123-30. PMID: 25451828.
      View in: PubMed
    48. Andersson KE. The use of pharmacotherapy for male patients with urgency and stress incontinence. Curr Opin Urol. 2014 Nov; 24(6):571-7. PMID: 25144147.
      View in: PubMed
    49. Andersson KE. Potential of stem cell treatment in detrusor dysfunction. Adv Drug Deliv Rev. 2015 Mar; 82-83:117-22. PMID: 25453263.
      View in: PubMed
    50. Nomiya M, Andersson KE, Yamaguchi O. Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol. 2015 Jan; 22(1):40-6. PMID: 25339506.
      View in: PubMed
    51. Walker SJ, Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE. Transcriptome analysis of bladder biopsy from interstitial cystitis/bladder pain syndrome patients. Genom Data. 2014 Dec; 2:366-8. PMID: 26484132; PMCID: PMC4535940.
    52. Zarifpour M, Nomiya M, Sawada N, Andersson KE. Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia. Prostate. 2015 Feb 15; 75(3):233-41. PMID: 25327615; PMCID: PMC4305204.
    53. Bondza S, Stenberg J, Nestor M, Andersson K, Björkelund H. Conjugation effects on antibody-drug conjugates: evaluation of interaction kinetics in real time on living cells. Mol Pharm. 2014 Nov 03; 11(11):4154-63. PMID: 25252166.
      View in: PubMed
    54. Peng Z, Andersson K, Lindholm J, Bodin I, Pramana S, Pawitan Y, Nistér M, Nilsson S, Li C. Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells. PLoS One. 2014; 9(10):e109610. PMID: 25296164; PMCID: PMC4190108.
    55. Drumm BT, Koh SD, Andersson KE, Ward SM. Calcium signalling in Cajal-like interstitial cells of the lower urinary tract. Nat Rev Urol. 2014 Oct; 11(10):555-64. PMID: 25224445.
      View in: PubMed
    56. Andersson KE. Words of wisdom. Re: Tissue engineering of the bladder: reality or myth? A systematic review. Eur Urol. 2014 Sep; 66(3):593. PMID: 25306178.
      View in: PubMed
    57. Barta P, Volkova M, Dascalu A, Spiegelberg D, Trejtnar F, Andersson K. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay. J Pharmacol Toxicol Methods. 2014 Sep-Oct; 70(2):145-51. PMID: 25084055.
      View in: PubMed
    58. Kunit T, Gratzke C, Schreiber A, Strittmatter F, Waidelich R, Rutz B, Loidl W, Andersson KE, Stief CG, Hennenberg M. Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate. Am J Physiol Renal Physiol. 2014 Oct 01; 307(7):F823-32. PMID: 25056351.
      View in: PubMed
    59. Kim J, Andersson KE, Jackson JD, Lee SJ, Atala A, Yoo JJ. Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering. Tissue Eng Part A. 2014 Aug; 20(15-16):2265-72. PMID: 24524875; PMCID: PMC4137358.
    60. Andersson KE. The many faces of impaired bladder emptying. Curr Opin Urol. 2014 Jul; 24(4):363-9. PMID: 24752226.
      View in: PubMed
    61. Aro E, Bastman S, Andersson KE, Streng T. Is there a peripheral site of action contributing to the voiding effects of a2-adrenoceptor agonists and antagonists? World J Urol. 2015 Mar; 33(3):433-40. PMID: 24903349.
      View in: PubMed
    62. Andersson KE, Nomiya M, Sawada N, Yamaguchi O. Pharmacological treatment of chronic pelvic ischemia. Ther Adv Urol. 2014 Jun; 6(3):105-14. PMID: 24883108; PMCID: PMC4003842.
    63. Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. J Urol. 2014 Oct; 192(4):1123-9. PMID: 24840534.
      View in: PubMed
    64. Sunagawa M, Wolf-Johnston A, Nomiya M, Sawada N, Andersson KE, Hisamitsu T, Birder LA. Urinary bladder mucosal responses to ischemia. World J Urol. 2015 Feb; 33(2):275-80. PMID: 24728265; PMCID: PMC4194265.
    65. Van Kerrebroeck P, Andersson KE. Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn. 2014 Apr; 33 Suppl 1:S2-5. PMID: 24729150.
      View in: PubMed
    66. Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, Stief C, Hedlund P, Andersson KE. Bladder function in a cannabinoid receptor type 1 knockout mouse. BJU Int. 2014 Jan; 113(1):144-51. PMID: 24053792.
      View in: PubMed
    67. Yamagishi T, Ishizuka O, Imamura T, Yokoyama H, Ogawa T, Kurizaki Y, Nishizawa O, Andersson KE. Alpha1 -adrenergic receptors mediate bladder overactivity induced by cold stress in rats with bladder outlet obstruction. Neurourol Urodyn. 2015 Mar; 34(3):280-5. PMID: 24375712.
      View in: PubMed
    68. Dubois L, Andersson K, Asplund A, Björkelund H. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. BMC Res Notes. 2013 Dec 18; 6:542. PMID: 24350799; PMCID: PMC3878317.
    69. Gedda L, Björkelund H, Lebel L, Asplund A, Dubois L, Wester K, Penagos N, Malmqvist M, Andersson K. Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissue. Appl Immunohistochem Mol Morphol. 2013 Dec; 21(6):497-505. PMID: 23455178.
      View in: PubMed
    70. Yamaguchi O, Nomiya M, Andersson KE. Functional consequences of chronic bladder ischemia. Neurourol Urodyn. 2014 Jan; 33(1):54-8. PMID: 24292974.
      View in: PubMed
    71. Andersson KE. Bladder underactivity. Eur Urol. 2014 Feb; 65(2):399-401. PMID: 24268505.
      View in: PubMed
    72. Tremp M, Salemi S, Largo R, Andersson KE, Plock JA, Plock J, Aboushwareb T, Sulser T, Eberli D. Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction. World J Urol. 2014 Oct; 32(5):1241-8. PMID: 24217741.
      View in: PubMed
    73. Xu B, Varasteh Z, Orlova A, Andersson K, Larhammar D, Björkelund H. Detecting ligand interactions with G protein-coupled receptors in real-time on living cells. Biochem Biophys Res Commun. 2013 Nov 29; 441(4):820-4. PMID: 24211197.
      View in: PubMed
    74. Nomiya M, Yamaguchi O, Akaihata H, Hata J, Sawada N, Kojima Y, Andersson KE. Progressive vascular damage may lead to bladder underactivity in rats. J Urol. 2014 May; 191(5):1462-9. PMID: 24184364.
      View in: PubMed
    75. Andersson KE. ß3-receptor agonists for overactive bladder--new frontier or more of the same? Curr Urol Rep. 2013 Oct; 14(5):435-41. PMID: 23677692.
      View in: PubMed
    76. Hennenberg M, Miljak M, Herrmann D, Strittmatter F, Walther S, Rutz B, Hocaoglu Y, Kunit T, Schreiber A, Andersson KE, Stief CG, Gratzke C. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle. Am J Physiol Renal Physiol. 2013 Nov 15; 305(10):F1383-90. PMID: 24049147.
      View in: PubMed
    77. Burmeister DM, AbouShwareb T, Bergman CR, Andersson KE, Christ GJ. Age-related alterations in regeneration of the urinary bladder after subtotal cystectomy. Am J Pathol. 2013 Nov; 183(5):1585-95. PMID: 24012523; PMCID: PMC3814688.
    78. Andersson KE. Future therapies: Early trials and basic science. Can Urol Assoc J. 2013 Sep; 7(9-10 Suppl 4):S179-80. PMID: 24523838; PMCID: PMC3919188.
    79. Koslov DS, Andersson KE. Physiological and pharmacological aspects of the vas deferens-an update. Front Pharmacol. 2013; 4:101. PMID: 23986701; PMCID: PMC3749770.
    80. Campeau L, Soler R, Sittadjody S, Pareta R, Nomiya M, Zarifpour M, Opara EC, Yoo JJ, Andersson KE. Effects of allogeneic bone marrow derived mesenchymal stromal cell therapy on voiding function in a rat model of Parkinson disease. J Urol. 2014 Mar; 191(3):850-9. PMID: 23973520.
      View in: PubMed
    81. Gang W, Hongjian T, Jasheng C, Jiemin S, Zhong C, Yuemin X, Baojun G, Andersson KE. The effect of the 5-HT7 serotonin receptor agonist, LP44, on micturition in rats with chronic spinal cord injury. Neurourol Urodyn. 2014 Sep; 33(7):1165-70. PMID: 23861341.
      View in: PubMed
    82. Andersson KE, McCloskey KD. Lamina propria: the functional center of the bladder? Neurourol Urodyn. 2014 Jan; 33(1):9-16. PMID: 23847015.
      View in: PubMed
    83. Campeau L, Füllhase C, Sawada N, Gratzke C, Hedlund P, Howlett AC, Andersson KE. Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro. Neurourol Urodyn. 2014 Jun; 33(5):566-70. PMID: 23908133.
      View in: PubMed
    84. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Protective effect of a ß3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Eur Urol. 2013 Oct; 64(4):664-71. PMID: 23838637.
      View in: PubMed
    85. Christ GJ, Saul JM, Furth ME, Andersson KE. The pharmacology of regenerative medicine. Pharmacol Rev. 2013 Jul; 65(3):1091-133. PMID: 23818131; PMCID: PMC3698935.
    86. Soler R, Andersson KE, Chancellor MB, Chapple CR, de Groat WC, Drake MJ, Gratzke C, Lee R, Cruz F. Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol. 2013 Oct; 64(4):610-21. PMID: 23711541.
      View in: PubMed
    87. Badra S, Andersson KE, Dean A, Mourad S, Williams JK. Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency. J Urol. 2013 Nov; 190(5):1938-45. PMID: 23618586.
      View in: PubMed
    88. Andersson KE. New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA. Ther Clin Risk Manag. 2013; 9:161-70. PMID: 23637536; PMCID: PMC3634323.
    89. Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013 Apr; 93(2):653-80. PMID: 23589830; PMCID: PMC3768101.
    90. Füllhase C, Hennenberg M, Giese A, Schmidt M, Strittmatter F, Soler R, Gratzke C, Andersson KE, Stief C. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. J Urol. 2013 Oct; 190(4):1430-5. PMID: 23545097.
      View in: PubMed
    91. Altai M, Varasteh Z, Andersson K, Eek A, Boerman O, Orlova A. In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors. Cancer Biother Radiopharm. 2013 Apr; 28(3):187-95. PMID: 23461385.
      View in: PubMed
    92. Andersson KE, Martin N, Nitti V. Selective ß3-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013 Oct; 190(4):1173-80. PMID: 23458471.
      View in: PubMed
    93. Andersson KE. Animal in vivo models of lower urinary tract dysfunction: translational value. J Urol. 2013 May; 189(5):1622-3. PMID: 23454406.
      View in: PubMed
    94. Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ. The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials. 2013 Apr; 34(13):3246-55. PMID: 23391495.
      View in: PubMed
    95. Hicks AN, Campeau L, Burmeister D, Bishop CE, Andersson KE. Lack of nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2): consequences for mouse bladder development and function. Neurourol Urodyn. 2013 Nov; 32(8):1130-6. PMID: 23371862.
      View in: PubMed
    96. Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Yamaguchi O, Andersson KE. Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function. BJU Int. 2013 Jul; 112(2):E221-30. PMID: 23350885.
      View in: PubMed
    97. Andersson KE. Treatment of lower urinary tract symptoms: agents for intraprostatic injection. Scand J Urol. 2013 Apr; 47(2):83-90. PMID: 23281591.
      View in: PubMed
    98. Svalø J, Nordling J, Bouchelouche K, Andersson KE, Korstanje C, Bouchelouche P. The novel ß3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity. Eur J Pharmacol. 2013 Jan 15; 699(1-3):101-5. PMID: 23246623.
      View in: PubMed
    99. Ishizuka O, Imamura T, Kurizaki Y, Nishizawa O, Andersson KE. Male lower urinary tract symptoms and a1D-adrenoceptors. Int J Urol. 2013 Jan; 20(1):73-8. PMID: 23205498.
      View in: PubMed
    100. Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief C, Andersson KE, Hedlund P. Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol. 2013 Jun; 189(6):2364-70. PMID: 23219540.
      View in: PubMed
    101. Hennenberg M, Strittmatter F, Beckmann C, Rutz B, Füllhase C, Waidelich R, Montorsi F, Hedlund P, Andersson KE, Stief CG, Gratzke C. Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. PLoS One. 2012; 7(11):e50904. PMID: 23226423; PMCID: PMC3511420.
    102. Orlova A, Hofström C, Strand J, Varasteh Z, Sandstrom M, Andersson K, Tolmachev V, Gräslund T. [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. Eur J Nucl Med Mol Imaging. 2013 Feb; 40(3):439-49. PMID: 23179942.
      View in: PubMed
    103. Chen J, Gu B, Wu G, Tu H, Si J, Xu Y, Andersson KE. The effect of the 5-HT2A/2C receptor agonist DOI on micturition in rats with chronic spinal cord injury. J Urol. 2013 May; 189(5):1982-8. PMID: 23159275.
      View in: PubMed
    104. Hood B, Andersson KE. Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder. Int J Urol. 2013 Jan; 20(1):21-7. PMID: 23072271; PMCID: PMC3558796.
    105. Hicks AN, Lorenzetti D, Gilley J, Lu B, Andersson KE, Miligan C, Overbeek PA, Oppenheim R, Bishop CE. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo. PLoS One. 2012; 7(10):e47869. PMID: 23082226; PMCID: PMC3474723.
    106. Noguchi W, Ishizuka O, Imamura T, Kurizaki Y, Yamagishi T, Yokoyama H, Lei Z, Silwal SG, Nishizawa O, Andersson KE. The relationship between a1-adrenergic receptors and TRPM8 channels in detrusor overactivity induced by cold stress in ovariectomized rats. J Urol. 2013 May; 189(5):1975-81. PMID: 23069383.
      View in: PubMed
    107. Peyton CC, Burmeister D, Petersen B, Andersson KE, Christ G. Characterization of the early proliferative response of the rodent bladder to subtotal cystectomy: a unique model of mammalian organ regeneration. PLoS One. 2012; 7(10):e47414. PMID: 23077610; PMCID: PMC3470577.
    108. Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Keys T, Peyton C, Yamaguchi O, Andersson KE. Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia. J Urol. 2013 Feb; 189(2):754-61. PMID: 22982422.
      View in: PubMed
    109. Horst M, Heutschi J, van den Brand R, Andersson KE, Gobet R, Sulser T, Courtine G, Eberli D. Multisystem neuroprosthetic training improves bladder function after severe spinal cord injury. J Urol. 2013 Feb; 189(2):747-53. PMID: 22982431.
      View in: PubMed
    110. Badra S, Andersson KE, Dean A, Mourad S, Williams JK. A nonhuman primate model of stable urinary sphincter deficiency. J Urol. 2013 May; 189(5):1967-74. PMID: 23022012.
      View in: PubMed
    111. Lei Z, Ishizuka O, Imamura T, Noguchi W, Yamagishi T, Yokoyama H, Kurizaki Y, Sudha GS, Hosoda T, Nishizawa O, Andersson KE. Functional roles of transient receptor potential melastatin 8 (TRPM8) channels in the cold stress-induced detrusor overactivity pathways in conscious rats. Neurourol Urodyn. 2013 Jun; 32(5):500-4. PMID: 23001687.
      View in: PubMed
    112. Gratzke C, Andersson KE. a-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on. Eur Urol. 2013 Jan; 63(1):166-7; discussion 168. PMID: 22959051.
      View in: PubMed
    113. Ekerljung L, Wållberg H, Sohrabian A, Andersson K, Friedman M, Frejd FY, Ståhl S, Gedda L. Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2. Bioconjug Chem. 2012 Sep 19; 23(9):1802-11. PMID: 22882002.
      View in: PubMed
    114. Andersson KE. Drugs for lower urinary tract symptoms--anything new? J Urol. 2012 Aug; 188(2):349-50. PMID: 22704116.
      View in: PubMed
    115. Kurizaki Y, Ishizuka O, Imamura T, Ishikawa M, Ichino M, Ogawa T, Nishizawa O, Andersson KE. Relationship between expression of ß3-adrenoceptor mRNA in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Neurourol Urodyn. 2013 Jan; 32(1):88-91. PMID: 22692629.
      View in: PubMed
    116. Li K, Yao J, Sawada N, Kitamura M, Andersson KE, Takeda M. ß-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol. 2012 Jul; 188(1):307-15. PMID: 22608743.
      View in: PubMed
    117. Burmeister D, AbouShwareb T, D'Agostino R, Andersson KE, Christ GJ. Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²? signaling regulators. Am J Physiol Renal Physiol. 2012 Jun 15; 302(12):F1517-28. PMID: 22442207; PMCID: PMC3962544.
    118. Malykhina AP, Wyndaele JJ, Andersson KE, De Wachter S, Dmochowski RR. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):352-8. PMID: 22378593; PMCID: PMC3309116.
    119. Soler R, Füllhase C, Hanson A, Campeau L, Santos C, Andersson KE. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease. J Urol. 2012 Apr; 187(4):1491-7. PMID: 22341818.
      View in: PubMed
    120. Streng T, Andersson KE, Hedlund P, Gratzke C, Baroni E, D'Ambrosio D, Benigni F. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction. BJU Int. 2012 Jul; 110(2 Pt 2):E125-31. PMID: 22288904.
      View in: PubMed
    121. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Mechanisms of action of botulinum neurotoxins, ß3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):300-8. PMID: 22275187.
      View in: PubMed
    122. Campeau L, Soler R, Andersson KE. Bladder dysfunction and parkinsonism: current pathophysiological understanding and management strategies. Curr Urol Rep. 2011 Dec; 12(6):396-403. PMID: 21986769.
      View in: PubMed
    123. Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development. Vaccine. 2012 Jan 05; 30(2):225-30. PMID: 22079080.
      View in: PubMed
    124. Andersson KE. Drugs and future candidates. Can Urol Assoc J. 2011 Oct; 5(5 Suppl 2):S131-3. PMID: 21989523; PMCID: PMC3193394.
    125. Nomiya M, Sagawa K, Yazaki J, Takahashi N, Kushida N, Haga N, Aikawa K, Matsui T, Oka M, Fukui T, Andersson KE, Yamaguchi O. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn. 2012 Jan; 31(1):185-9. PMID: 21953769.
      View in: PubMed
    126. Björkelund H, Gedda L, Barta P, Malmqvist M, Andersson K. Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²5I-EGF. PLoS One. 2011; 6(9):e24739. PMID: 21931838; PMCID: PMC3171474.
    127. Nomiya M, Yamaguchi O, Andersson KE, Sagawa K, Aikawa K, Shishido K, Yanagida T, Kushida N, Yazaki J, Takahashi N. The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat. Neurourol Urodyn. 2012 Jan; 31(1):195-200. PMID: 21905085.
      View in: PubMed
    128. Andersson KE. Neurourology and Urodynamics. Editorial. Neurourol Urodyn. 2011 Sep; 30(7):1207. PMID: 21887752.
      View in: PubMed
    129. Campeau L, Gorbachinsky I, Badlani GH, Andersson KE. Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int. 2011 Oct; 108(8):1240-7. PMID: 21883823.
      View in: PubMed
    130. Andersson KE, Abdel-Hamid IA. Therapeutic targets for premature ejaculation. Maturitas. 2011 Sep; 70(1):26-33. PMID: 21816550.
      View in: PubMed
    131. Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, Zhang Y. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011 Aug; 17(15-16):2123-32. PMID: 21513463.
      View in: PubMed
    132. Andersson KE, Campeau L, Olshansky B. Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol. 2011 Aug; 72(2):186-96. PMID: 21595741; PMCID: PMC3162648.
    133. Jin LH, Andersson KE, Han JU, Kwon YH, Park CS, Shin HY, Yoon SM, Lee T. Persistent detrusor overactivity in rats after relief of partial urethral obstruction. Am J Physiol Regul Integr Comp Physiol. 2011 Oct; 301(4):R896-904. PMID: 21795634.
      View in: PubMed
    134. Andersson KE. Peer review: "a critique of the critics". J Urol. 2011 Sep; 186(3):777-8. PMID: 21788036.
      View in: PubMed
    135. Gu B, Wu G, Si J, Xu Y, Andersson KE. Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist. Neurourol Urodyn. 2012 Jan; 31(1):168-73. PMID: 21780177.
      View in: PubMed
    136. Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE. Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int. 2012 Feb; 109(4):572-80. PMID: 21777361.
      View in: PubMed
    137. Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol. 2011 Oct; 60(4):784-95. PMID: 21782318.
      View in: PubMed
    138. Radziszewski P, Crayton R, Persson K, Andersson KE, Mattiasson A. Exogenously administered bombesin and gastrin releasing peptide contract the female rat urethra in vivo and in vitro. Neurourol Urodyn. 2011 Nov; 30(8):1681-5. PMID: 21717499.
      View in: PubMed
    139. Füllhase C, Soler R, Westerling-Andersson K, Andersson KE. Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction. Neurourol Urodyn. 2011 Sep; 30(7):1382-7. PMID: 21661032.
      View in: PubMed
    140. Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Researching bladder afferents-determining the effects of ß(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011 Jun; 30(5):684-91. PMID: 21661014.
      View in: PubMed
    141. Andersson KE, Soler R, Füllhase C. Rodent models for urodynamic investigation. Neurourol Urodyn. 2011 Jun; 30(5):636-46. PMID: 21661007.
      View in: PubMed
    142. Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE. Assessment of Association of Increased Heart Rates to Cardiovascular Events among Healthy Subjects in the United States: Analysis of a Primary Care Electronic Medical Records Database. ISRN Cardiol. 2011; 2011:924343. PMID: 22347663; PMCID: PMC3262494.
    143. Hennenberg M, Strittmatter F, Walther S, Hedlund P, Andersson KE, Stief CG, Schlenker B, Gratzke C. a1-adrenoceptor activation induces phosphorylation of ß2-adrenoceptors in human prostate tissue. BJU Int. 2011 Sep; 108(6):922-8. PMID: 21371241.
      View in: PubMed
    144. Bauer RM, Strittmatter F, Gratzke C, Göttinger J, Schlenker B, Reich O, Stief CG, Hedlund P, Andersson KE, Hennenberg M. Coupling of a1-adrenoceptors to ERK1/2 in the human prostate. Urol Int. 2011; 86(4):427-33. PMID: 21293101.
      View in: PubMed
    145. Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, Wyndaele JJ, Melby T, Viktrup L. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 2011 Mar; 30(3):292-301. PMID: 21284024.
      View in: PubMed
    146. Björkelund H, Gedda L, Andersson K. Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context. PLoS One. 2011 Jan 31; 6(1):e16536. PMID: 21304974; PMCID: PMC3031572.
    147. Nielsen JS, Rode F, Rahbek M, Andersson KE, Rønn LC, Bouchelouche K, Nordling J, Bouchelouche P. Effect of the SK/IK channel modulator 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591) on contractile force in rat, pig and human detrusor smooth muscle. BJU Int. 2011 Sep; 108(5):771-7. PMID: 21223472.
      View in: PubMed
    148. Abdel-Hamid IA, Andersson KE, Salonia A. Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories. Expert Opin Ther Targets. 2011 Mar; 15(3):325-40. PMID: 21204729.
      View in: PubMed
    149. Björkelund H, Gedda L, Andersson K. Avoiding false negative results in specificity analysis of protein-protein interactions. J Mol Recognit. 2011 Jan-Feb; 24(1):81-9. PMID: 21194119.
      View in: PubMed
    150. Russo A, Castiglione F, Salonia A, Benigni F, Rigatti P, Montorsi F, Andersson KE, Hedlund P. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats. Eur Urol. 2011 May; 59(5):868-74. PMID: 21196074.
      View in: PubMed
    151. Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE. Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction. J Urol. 2011 Feb; 185(2):731-6. PMID: 21168864.
      View in: PubMed
    152. Andersson KE. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol. 2011 Mar; 59(3):377-86. PMID: 21168951.
      View in: PubMed
    153. Thüroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, Hampel C, Neisius A, Schröder A, Tubaro A. EAU guidelines on urinary incontinence. Eur Urol. 2011 Mar; 59(3):387-400. PMID: 21130559.
      View in: PubMed
    154. Streng T, Santti R, Andersson KE. Voiding effects mediated by a2-adrenoceptors in the anaesthetized male rat. BJU Int. 2010 Nov; 106(10):1546-9. PMID: 20151962.
      View in: PubMed
    155. Strittmatter F, Gratzke C, Weinhold P, Steib CJ, Hartmann AC, Schlenker B, Andersson KE, Hedlund P, Stief CG, Hennenberg M. Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms. Eur J Pharmacol. 2011 Jan 15; 650(2-3):650-5. PMID: 21044618.
      View in: PubMed
    156. Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y, Nishizawa O, Andersson KE. Relation between expression of a(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2011 Feb; 45(1):15-9. PMID: 20961266.
      View in: PubMed
    157. Limberg BJ, Andersson KE, Aura Kullmann F, Burmer G, de Groat WC, Rosenbaum JS. ß-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res. 2010 Nov; 342(2):295-306. PMID: 20953633; PMCID: PMC3113530.
    158. Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K, Xin ZC. Future sexual medicine physiological treatment targets. J Sex Med. 2010 Oct; 7(10):3269-304. PMID: 21029380.
      View in: PubMed
    159. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int. 2010 Oct; 106(8):1114-27. PMID: 21156013.
      View in: PubMed
    160. Aizawa N, Iijima K, Rosenbaum JS, Downs TR, Igawa Y, Andersson KE, Wyndaele JJ. Comparison of the effects of oestrogen deficiency and old age on primary bladder afferent activity and voiding behaviour in the ageing female rat. BJU Int. 2011 Jul; 108(2 Pt 2):E10-6. PMID: 20875090.
      View in: PubMed
    161. Andersson KE. Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol. 2010 Nov; 184(5):1829-30. PMID: 20846686.
      View in: PubMed
    162. Jin LH, Andersson KE, Kwon YH, Yoon SM, Lee T. Selection of a control rat for conscious spontaneous hypertensive rats in studies of detrusor overactivity on the basis of measurement of intra-abdominal pressures. Neurourol Urodyn. 2010 Sep; 29(7):1338-43. PMID: 20879003.
      View in: PubMed
    163. Burmeister D, Aboushwareb T, Tan J, Link K, Andersson KE, Christ G. Early stages of in situ bladder regeneration in a rodent model. Tissue Eng Part A. 2010 Aug; 16(8):2541-51. PMID: 20235833; PMCID: PMC2947436.
    164. Aizawa N, Igawa Y, Andersson KE, Iijima K, Nishizawa O, Wyndaele JJ. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity. Neurourol Urodyn. 2011 Jan; 30(1):163-8. PMID: 20665548.
      View in: PubMed
    165. Soler R, Füllhase C, Santos C, Andersson KE. Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol Urodyn. 2011 Jan; 30(1):188-93. PMID: 20589898.
      View in: PubMed
    166. Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. J Urol. 2010 Aug; 184(2):783-9. PMID: 20639056.
      View in: PubMed
    167. Gedda L, Björkelund H, Andersson K. Real-time immunohistochemistry analysis of embedded tissue. Appl Radiat Isot. 2010 Dec; 68(12):2372-6. PMID: 20828661.
      View in: PubMed
    168. Zhao W, Aboushwareb T, Turner C, Mathis C, Bennett C, Sonntag WE, Andersson KE, Christ G. Impaired bladder function in aging male rats. J Urol. 2010 Jul; 184(1):378-85. PMID: 20488483; PMCID: PMC2963021.
    169. Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P. TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol. 2010 May; 183(5):2070-6. PMID: 20303522.
      View in: PubMed
    170. Chen Z, Ishizuka O, Imamura T, Aizawa N, Kurizaki Y, Igawa Y, Nishizawa O, Andersson KE. Stimulation of skin menthol receptors stimulates detrusor activity in conscious rats. Neurourol Urodyn. 2010 Mar; 29(3):506-11. PMID: 19618444.
      View in: PubMed
    171. Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol. 2010 Jun; 57(6):1093-100. PMID: 20207474.
      View in: PubMed
    172. Kanai A, Andersson KE. Bladder afferent signaling: recent findings. J Urol. 2010 Apr; 183(4):1288-95. PMID: 20171668; PMCID: PMC3686308.
    173. Soler R, Füllhase C, Lu B, Bishop CE, Andersson KE. Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide? J Urol. 2010 Feb; 183(2):780-5. PMID: 20022053; PMCID: PMC3772662.
    174. Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010; 29(1):97-106. PMID: 20025035.
      View in: PubMed
    175. Andersson KE. Words of wisdom. Re: Spontaneous release of acetylcholine from autonomic nerves in the bladder. Eur Urol. 2010 Jan; 57(1):171-2. PMID: 20178729.
      View in: PubMed
    176. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010 Jan; 7(1 Pt 2):445-75. PMID: 20092448.
      View in: PubMed
    177. Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int. 2010 Jul; 106(2):268-74. PMID: 19922546.
      View in: PubMed
    178. Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction. BJU Int. 2010 Jul; 106(2):287-93. PMID: 19888972.
      View in: PubMed
    179. Andersson KE. Pharmacotherapy of the overactive bladder. Discov Med. 2009 Oct; 8(42):118-24. PMID: 19833057.
      View in: PubMed
    180. Abdel-Hamid IA, Andersson KE. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Pharmacogenomics. 2009 Oct; 10(10):1625-44. PMID: 19842936.
      View in: PubMed
    181. Andersson KE. Prostanoid receptor subtypes: new targets for OAB drugs? J Urol. 2009 Nov; 182(5):2099-100. PMID: 19758658.
      View in: PubMed
    182. Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P. Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol. 2010 May; 57(5):902-10. PMID: 19733001.
      View in: PubMed
    183. Werkström V, Hedlund P, Lee T, Andersson KE. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder. BJU Int. 2009 Dec; 104(11):1740-5. PMID: 19694713.
      View in: PubMed
    184. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9. PMID: 19683859.
      View in: PubMed
    185. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol. 2009 Jul; 19(4):380-94. PMID: 19448545.
      View in: PubMed
    186. Andersson KE. Prospective pharmacologic therapies for the overactive bladder. Ther Adv Urol. 2009 Jun; 1(2):71-83. PMID: 21789056; PMCID: PMC3126054.
    187. Zhao W, Sato Y, Melman A, Andersson KE, Christ G. Metrics for evaluation of age-related changes in erectile capacity in a rodent model. J Sex Med. 2009 Jul; 6(7):1885-92. PMID: 19453894.
      View in: PubMed
    188. Ekman M, Andersson KE, Arner A. Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca2+ channels. BJU Int. 2009 Sep; 104(5):690-7. PMID: 19388992.
      View in: PubMed
    189. Gratzke C, Streng T, Park A, Christ G, Stief CG, Hedlund P, Andersson KE. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol. 2009 Apr; 181(4):1939-48. PMID: 19237169.
      View in: PubMed
    190. Abdel-Hamid IA, Jannini EA, Andersson KE. Premature ejaculation: focus on therapeutic targets. Expert Opin Ther Targets. 2009 Feb; 13(2):175-93. PMID: 19236236.
      View in: PubMed
    191. Gratzke C, Christ GJ, Stief CG, Andersson KE, Hedlund P. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur Urol. 2010 Feb; 57(2):342-8. PMID: 19147270.
      View in: PubMed
    192. Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D'Agostino R, Sun TT, Christ GJ. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009; 28(8):1028-33. PMID: 19267388; PMCID: PMC4048927.
    193. Imamura T, Ishizuka O, Zhong C, Ogawa T, Nakayama T, Kurizaki Y, Tanabe T, Nishizawa O, Andersson KE. An extract (THC-002) of Ba-Wei-Die-Huang-Wan inhibits expression of tachykinins, and P2X3 and TRPV1 receptors, and inhibits ATP-induced detrusor overactivity in spontaneously hypertensive rats. Neurourol Urodyn. 2009; 28(6):529-34. PMID: 19283865.
      View in: PubMed
    194. Chen Z, Ishizuka O, Imamura T, Aizawa N, Igawa Y, Nishizawa O, Andersson KE. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats. Neurourol Urodyn. 2009; 28(3):251-6. PMID: 18837433.
      View in: PubMed
    195. Jin LH, Andersson KE, Kwon YH, Park CS, Yoon SM, Lee T. Substantial detrusor overactivity in conscious spontaneously hypertensive rats with hyperactive behaviour. Scand J Urol Nephrol. 2009; 43(1):3-7. PMID: 19034716.
      View in: PubMed
    196. Christ GJ, Andersson KE, Williams K, Zhao W, D'Agostino R, Kaplan J, Aboushwareb T, Yoo J, Calenda G, Davies KP, Sellers RS, Melman A. Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol. 2009 Dec; 56(6):1055-66. PMID: 19167152.
      View in: PubMed
    197. Andersson KE, Fullhase C, Soler R. Urothelial effects of oral agents for overactive bladder. Curr Urol Rep. 2008 Nov; 9(6):459-64. PMID: 18947510.
      View in: PubMed
    198. Andersson KE. Are female lower urinary tract symptoms alleviated by alpha-adrenoreceptor antagonists? Nat Clin Pract Urol. 2008 Nov; 5(11):586-7. PMID: 18825132.
      View in: PubMed
    199. Gratzke C, Jarajapu YP, Christ GJ, Kaplan JR, Williams JK, Andersson KE, Badlani G. Effects of long-term dietary soy treatment on female urethral morphology and function in ovariectomized nonhuman primates. J Urol. 2008 Nov; 180(5):2247-53. PMID: 18804802.
      View in: PubMed
    200. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180(5):2226-33. PMID: 18804817.
      View in: PubMed
    201. Eberli D, Andersson KE, Yoo JJ, Atala A. A canine model of irreversible urethral sphincter insufficiency. BJU Int. 2009 Jan; 103(2):248-53. PMID: 18782310.
      View in: PubMed
    202. Ekman M, Andersson KE, Arner A. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder. BJU Int. 2009 Jan; 103(1):90-7. PMID: 18727613.
      View in: PubMed
    203. Andersson KE. How many drugs for LUTS due to BPH are too many? J Urol. 2008 Sep; 180(3):811-2. PMID: 18635235.
      View in: PubMed
    204. Aizawa N, Ishizuka O, Ogawa T, Mizusawa H, Igawa Y, Nishizawa O, Andersson KE. Effects of natriuretic peptides on intracavernous pressure and blood pressure in conscious rats. J Sex Med. 2008 Oct; 5(10):2312-7. PMID: 18624958.
      View in: PubMed
    205. Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84. PMID: 18489526.
      View in: PubMed
    206. Nestor M, Andersson K, Lundqvist H. Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay. J Mol Recognit. 2008 May-Jun; 21(3):179-83. PMID: 18438972.
      View in: PubMed
    207. Gratzke C, Streng T, Waldkirch E, Sigl K, Stief C, Andersson KE, Hedlund P. Transient receptor potential A1 (TRPA1) activity in the human urethra--evidence for a functional role for TRPA1 in the outflow region. Eur Urol. 2009 Mar; 55(3):696-704. PMID: 18468780.
      View in: PubMed
    208. Hodges SJ, Zhou G, Deng FM, Aboushwareb T, Turner C, Andersson KE, Santago P, Case D, Sun TT, Christ GJ. Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout mice. J Urol. 2008 May; 179(5):2046-51. PMID: 18355864.
      View in: PubMed
    209. Hipp JA, Hipp JD, Yoo JJ, Atala A, Andersson KE. Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int. 2008 Sep; 102(6):741-6. PMID: 18336610.
      View in: PubMed
    210. Ney P, Pandita RK, Newgreen DT, Breidenbach A, Stöhr T, Andersson KE. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. BJU Int. 2008 Apr; 101(8):1036-42. PMID: 18279452.
      View in: PubMed
    211. Gomez-Pinilla PJ, Gomez MF, Swärd K, Hedlund P, Hellstrand P, Camello PJ, Andersson KE, Pozo MJ. Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res. 2008 May; 44(4):416-25. PMID: 18194201.
      View in: PubMed
    212. Lee T, Andersson KE, Streng T, Hedlund P. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2. Neurourol Urodyn. 2008; 27(1):88-95. PMID: 17565725.
      View in: PubMed
    213. Lu B, Poirier C, Gaspar T, Gratzke C, Harrison W, Busija D, Matzuk MM, Andersson KE, Overbeek PA, Bishop CE. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol Reprod. 2008 Apr; 78(4):601-10. PMID: 18094351.
      View in: PubMed
    214. Andersson KE, Olshansky B. Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations. BJU Int. 2007 Nov; 100(5):1007-14. PMID: 17922785.
      View in: PubMed
    215. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007 Nov; 100(5):987-1006. PMID: 17922784.
      View in: PubMed
    216. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, Andersson KE, Högestätt ED, Zygmunt PM. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol. 2008 Feb; 53(2):391-9. PMID: 18031925.
      View in: PubMed
    217. Andersson KE, Uckert S, Stief C, Hedlund P. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn. 2007 Oct; 26(6 Suppl):928-33. PMID: 17806124.
      View in: PubMed
    218. Christ GJ, Andersson KE. Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Neurourol Urodyn. 2007 Oct; 26(6 Suppl):948-54. PMID: 17696159.
      View in: PubMed
    219. Hipp J, Andersson KE, Kwon TG, Kwak EK, Yoo J, Atala A. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int. 2008 Jan; 101(1):100-5. PMID: 17868416.
      View in: PubMed
    220. Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol. 2007 Jul; 4(7):368-78. PMID: 17615548.
      View in: PubMed
    221. Hedlund P, Streng T, Lee T, Andersson KE. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. J Urol. 2007 Jul; 178(1):326-31. PMID: 17507042.
      View in: PubMed
    222. Gomez-Pinilla PJ, Gomez MF, Hedlund P, Swärd K, Hellstrand P, Camello PJ, Pozo MJ, Andersson KE. Effect of melatonin on age associated changes in Guinea pig bladder function. J Urol. 2007 Apr; 177(4):1558-61. PMID: 17382778.
      View in: PubMed
    223. Andersson KE, Christ GJ. Regenerative pharmacology: the future is now. Mol Interv. 2007 Apr; 7(2):79-86. PMID: 17468388.
      View in: PubMed
    224. Lee T, Hedlund P, Newgreen D, Andersson KE. Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol. 2007 Apr; 177(4):1562-7. PMID: 17382779.
      View in: PubMed
    225. Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. Cancer Res. 2007 Mar 15; 67(6):2773-82. PMID: 17363599.
      View in: PubMed
    226. Bivalacqua TJ, Kendirci M, Champion HC, Hellstrom WJ, Andersson KE, Hedlund P. Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha. BJU Int. 2007 Jun; 99(6):1488-94. PMID: 17355372.
      View in: PubMed
    227. Christ G, Andersson KE, Atala A. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering. Curr Urol Rep. 2007 Mar; 8(2):95-9. PMID: 17303012.
      View in: PubMed
    228. Waldkirch ES, Uckert S, Langnäse K, Richter K, Jonas U, Wolf G, Andersson KE, Stief CG, Hedlund P. Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol. 2007 Aug; 52(2):495-501. PMID: 17329019.
      View in: PubMed
    229. Sjöqvist F, Eriksson LO, Andersson KE. Merck fellowships contribute to the continued growth of clinical pharmacology in Sweden. Eur J Clin Pharmacol. 2007 Mar; 63(3):229-31. PMID: 17235553.
      View in: PubMed
    230. Albrecht K, Uckert S, Oelke M, Andersson KE, Jonas U, Tröger HD, Hedlund P. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value? J Forensic Leg Med. 2007 Jul; 14(5):270-4. PMID: 17113813.
      View in: PubMed
    231. Pandita RK, Rønn LC, Jensen BS, Andersson KE. Urodynamic effects of intravesical administration of the new small/intermediate conductance calcium activated potassium channel activator NS309 in freely moving, conscious rats. J Urol. 2006 Sep; 176(3):1220-4. PMID: 16890729.
      View in: PubMed
    232. Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006 Sep; 98(3):503-7. PMID: 16925744.
      View in: PubMed
    233. Schröder A, Colli E, Maggi M, Andersson KE. Effects of a vitamin D(3) analogue in a rat model of bladder outlet obstruction. BJU Int. 2006 Sep; 98(3):637-42. PMID: 16925765.
      View in: PubMed
    234. Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol. 2006 Dec; 50(6):1194-207; discussion 1207. PMID: 16815627.
      View in: PubMed
    235. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006 Jul; 148(5):565-78. PMID: 16751797; PMCID: PMC1751864.
    236. Lagou M, De Vente J, Kirkwood TB, Hedlund P, Andersson KE, Gillespie JI, Drake MJ. Location of interstitial cells and neurotransmitters in the mouse bladder. BJU Int. 2006 Jun; 97(6):1332-7. PMID: 16686734.
      View in: PubMed
    237. Streng T, Hedlund P, Talo A, Andersson KE, Gillespie JI. Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat. BJU Int. 2006 May; 97(5):1094-101. PMID: 16643498.
      View in: PubMed
    238. Tolmachev V, Nilsson FY, Widström C, Andersson K, Rosik D, Gedda L, Wennborg A, Orlova A. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J Nucl Med. 2006 May; 47(5):846-53. PMID: 16644755.
      View in: PubMed
    239. Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Uckert S. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 2006 May; 67(5):1111-6. PMID: 16635522.
      View in: PubMed
    240. Werkström V, Svensson A, Andersson KE, Hedlund P. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int. 2006 Aug; 98(2):414-23. PMID: 16626307.
      View in: PubMed
    241. Björke H, Andersson K. Automated, high-resolution cellular retention and uptake studies in vitro. Appl Radiat Isot. 2006 Aug; 64(8):901-5. PMID: 16618544.
      View in: PubMed
    242. Benigni F, Baroni E, Zecevic M, Zvara P, Streng T, Hedlund P, Colli E, D'Ambrosio D, Andersson KE. Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis. BJU Int. 2006 Mar; 97(3):617-24. PMID: 16469037.
      View in: PubMed
    243. Ekman M, Andersson KE, Arner A. Developmental regulation of nerve and receptor mediated contractions of mammalian urinary bladder smooth muscle. Eur J Pharmacol. 2006 Feb 17; 532(1-2):99-106. PMID: 16466651.
      View in: PubMed
    244. Lagou M, Gillespie JI, Andersson KE, Kirkwood T, Drake MJ. Bladder volume alters cholinergic responses of the isolated whole mouse bladder. J Urol. 2006 Feb; 175(2):771-6. PMID: 16407048.
      View in: PubMed
    245. Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int. 2006 Feb; 97(2):311-5. PMID: 16430636.
      View in: PubMed
    246. Andersson KE. Tachykinins: role in detrusor overactivity? Eur Urol. 2006 Mar; 49(3):423-5. PMID: 16426732.
      View in: PubMed
    247. Werkström V, Andersson KE. ATP- and adenosine-induced relaxation of the smooth muscle of the pig urethra. BJU Int. 2005 Dec; 96(9):1386-91. PMID: 16287463.
      View in: PubMed
    248. Waldkirch E, Uckert S, Yildirim H, Sohn M, Jonas U, Stief CG, Andersson KE, Hedlund P. Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance. World J Urol. 2005 Dec; 23(6):405-10. PMID: 16292559.
      View in: PubMed
    249. Streng TK, Talo A, Andersson KE, Santti R. A dose-dependent dual effect of oestrogen on voiding in the male mouse? BJU Int. 2005 Nov; 96(7):1126-30. PMID: 16225541.
      View in: PubMed
    250. Klausner AP, Streng T, Na YG, Raju J, Batts TW, Tuttle JB, Andersson KE, Steers WD. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci. 2005 Dec 30; 123(1-2):26-35. PMID: 16256445.
      View in: PubMed
    251. Persson M, Tolmachev V, Andersson K, Gedda L, Sandström M, Carlsson J. [(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells. Eur J Nucl Med Mol Imaging. 2005 Dec; 32(12):1457-62. PMID: 16193312.
      View in: PubMed
    252. Matsumoto K, Yoshida M, Andersson KE, Hedlund P. Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum. Br J Pharmacol. 2005 Sep; 146(2):259-67. PMID: 16025145; PMCID: PMC1576267.
    253. Hedlund P, Matsumoto K, Andersson KE. Animal models of erectile dysfunction. Curr Protoc Pharmacol. 2005 Jul; Chapter 5:Unit5.41. PMID: 21953393.
      View in: PubMed
    254. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005 Apr; 95(6):733-8. PMID: 15794773.
      View in: PubMed
    255. Uckert S, Oelke M, Waldkirch E, Stief CG, Albrecht K, Tröger HD, Jonas U, Andersson KE, Hedlund P. Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves. Urology. 2005 Mar; 65(3):604-10. PMID: 15780401.
      View in: PubMed
    256. Andersson KE. Mechanisms of Disease: central nervous system involvement in overactive bladder syndrome. Nat Clin Pract Urol. 2004 Dec; 1(2):103-8. PMID: 16474523.
      View in: PubMed
    257. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004 Dec; 56(4):581-631. PMID: 15602011.
      View in: PubMed
    258. Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, Manabe T, Matsui M, Andersson KE. Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J Urol. 2004 Dec; 172(6 Pt 1):2460-4. PMID: 15538291.
      View in: PubMed
    259. Crescioli C, Morelli A, Adorini L, Ferruzzi P, Luconi M, Vannelli GB, Marini M, Gelmini S, Fibbi B, Donati S, Villari D, Forti G, Colli E, Andersson KE, Maggi M. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab. 2005 Feb; 90(2):962-72. PMID: 15572423.
      View in: PubMed
    260. Streng T, Christoph T, Andersson KE. Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats. J Urol. 2004 Nov; 172(5 Pt 1):2054-8. PMID: 15540788.
      View in: PubMed
    261. Streng T, Talo A, Andersson KE. Transmitters contributing to the voiding contraction in female rats. BJU Int. 2004 Oct; 94(6):910-4. PMID: 15476534.
      View in: PubMed
    262. Schröder A, Newgreen D, Andersson KE. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol. 2004 Sep; 172(3):1166-70. PMID: 15311063.
      View in: PubMed
    263. Schröder A, Tajimi M, Matsumoto H, Schröder C, Brands M, Andersson KE. Protective effect of an oral endothelin converting enzyme inhibitor on rat detrusor function after outlet obstruction. J Urol. 2004 Sep; 172(3):1171-4. PMID: 15311064.
      View in: PubMed
    264. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004 Jul; 84(3):935-86. PMID: 15269341.
      View in: PubMed
    265. Streng T, Santti R, Andersson KE, Talo A. The role of the rhabdosphincter in female rat voiding. BJU Int. 2004 Jul; 94(1):138-42. PMID: 15217449.
      View in: PubMed
    266. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004 Jul; 1(1):6-23. PMID: 16422979.
      View in: PubMed
    267. Malmqvist U, Hedlund P, Swärd K, Andersson KE. Female pig urethral tone is dependent on Rho guanosine triphosphatases and Rho-associated kinase. J Urol. 2004 May; 171(5):1955-8. PMID: 15076320.
      View in: PubMed
    268. Brioni JD, Moreland RB, Cowart M, Hsieh GC, Stewart AO, Hedlund P, Donnelly-Roberts DL, Nakane M, Lynch JJ, Kolasa T, Polakowski JS, Osinski MA, Marsh K, Andersson KE, Sullivan JP. Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc Natl Acad Sci U S A. 2004 Apr 27; 101(17):6758-63. PMID: 15087502; PMCID: PMC404118.
    269. Uckert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG. Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol. 2004 Oct; 22(4):261-6. PMID: 15045518.
      View in: PubMed
    270. Andersson KE. New pharmacologic targets for the treatment of the overactive bladder: an update. Urology. 2004 Mar; 63(3 Suppl 1):32-41. PMID: 15013650.
      View in: PubMed
    271. Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004 Jan; 3(1):46-53. PMID: 14693111.
      View in: PubMed
    272. Andersson KE. Detrusor contraction--Focus on muscarinic receptors. Scand J Urol Nephrol Suppl. 2004; (215):54-7. PMID: 15545197.
      View in: PubMed
    273. Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology. 2003 Nov; 62(5 Suppl 2):3-10. PMID: 14662401.
      View in: PubMed
    274. Pehrson R, Stenman E, Andersson KE. Effects of tramadol on rat detrusor overactivity induced by experimental cerebral infarction. Eur Urol. 2003 Oct; 44(4):495-9. PMID: 14499688.
      View in: PubMed
    275. Schröder A, Uvelius B, Newgreen D, Andersson KE. Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction? J Urol. 2003 Sep; 170(3):1017-21. PMID: 12913762.
      View in: PubMed
    276. Schröder A, Pandita RK, Hedlund P, Warner M, Gustafsson JA, Andersson KE. Estrogen receptor subtypes and afferent signaling in the bladder. J Urol. 2003 Sep; 170(3):1013-6. PMID: 12913761.
      View in: PubMed
    277. Johansson R, Andersson KE, Persson K. Nerve-mediated bladder contraction is impaired by cytokines: involvement of inducible nitric oxide synthase. Eur J Pharmacol. 2003 Aug 29; 476(3):221-7. PMID: 12969769.
      View in: PubMed
    278. Nehra A, Steers WD, Althof SE, Andersson KE, Burnett AL, Costabile RA, Goldstein I, Kloner RA, Lue TF, Morales A, Rosen RC, Shabsigh R, Siroky MB, King L. Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003 Aug; 170(2 Pt 2):S3-5. PMID: 12853765.
      View in: PubMed
    279. Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003 Aug; 170(2 Pt 2):S6-13; discussion S13-4. PMID: 12853766.
      View in: PubMed
    280. Drake MJ, Hedlund P, Harvey IJ, Pandita RK, Andersson KE, Gillespie JI. Partial outlet obstruction enhances modular autonomous activity in the isolated rat bladder. J Urol. 2003 Jul; 170(1):276-9. PMID: 12796704.
      View in: PubMed
    281. Pehrson R, Andersson KE. Tramadol inhibits rat detrusor overactivity caused by dopamine receptor stimulation. J Urol. 2003 Jul; 170(1):272-5. PMID: 12796703.
      View in: PubMed
    282. Ho KM, Borja MC, Persson K, Brading AF, Andersson KE. Expression of nitric oxide synthase immunoreactivity in the human female intramural striated urethral sphincter. J Urol. 2003 Jun; 169(6):2407-11. PMID: 12771807.
      View in: PubMed
    283. Pandita RK, Pehrson R, Christoph T, Friderichs E, Andersson KE. Actions of tramadol on micturition in awake, freely moving rats. Br J Pharmacol. 2003 Jun; 139(4):741-8. PMID: 12812997; PMCID: PMC1573893.
    284. Christ GJ, Day NS, Day M, Zhao W, Persson K, Pandita RK, Andersson KE. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. Am J Physiol Regul Integr Comp Physiol. 2003 May; 284(5):R1241-8. PMID: 12676745.
      View in: PubMed
    285. Zhang X, Igawa Y, Ishizuka O, Nishizawa O, Andersson KE. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Naunyn Schmiedebergs Arch Pharmacol. 2003 May; 367(5):473-9. PMID: 12700886.
      View in: PubMed
    286. Drake MJ, Hedlund P, Andersson KE, Brading AF, Hussain I, Fowler C, Landon DN. Morphology, phenotype and ultrastructure of fibroblastic cells from normal and neuropathic human detrusor: absence of myofibroblast characteristics. J Urol. 2003 Apr; 169(4):1573-6. PMID: 12629418.
      View in: PubMed
    287. Andersson KE, Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs. 2003; 63(23):2595-611. PMID: 14636079.
      View in: PubMed
    288. Christ GJ, Venkateswarlu K, Day NS, Valcic M, Santizo C, Zhao W, Wang HZ, Persson K, Andersson KE. Intercellular communication and bladder function. Adv Exp Med Biol. 2003; 539(Pt A):239-54. PMID: 15088908.
      View in: PubMed
    289. Pehrson R, Lehmann A, Andersson KE. Effects of gamma-aminobutyrate B receptor modulation on normal micturition and oxyhemoglobin induced detrusor overactivity in female rats. J Urol. 2002 Dec; 168(6):2700-5. PMID: 12442013.
      View in: PubMed
    290. Staskin DR, Wein AJ, Andersson KE, Bauer SB, Blaivas JG, Burgio KL, Cardozo L, Chapple CR, Dmochowski RR, Gupta S, Mostwin JL, Ouslander JG, Weiss JP, King L. Overview consensus statement. Urology. 2002 Nov; 60(5 Suppl 1):1-6. PMID: 12493341.
      View in: PubMed
    291. Ishizuka O, Gu BJ, Yang ZX, Nishizawa O, Andersson KE. Functional role of central muscarinic receptors for micturition in normal conscious rats. J Urol. 2002 Nov; 168(5):2258-62. PMID: 12394771.
      View in: PubMed
    292. Andersson KE, Hedlund P. Pharmacologic perspective on the physiology of the lower urinary tract. Urology. 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PMID: 12493344.
      View in: PubMed
    293. Pehrson R, Ojteg G, Ishizuka O, Andersson KE. Effects of NAD-299, a new, highly selective 5-HT1A receptor antagonist, on bladder function in rats. Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec; 366(6):528-36. PMID: 12444493.
      View in: PubMed
    294. Küthe A, Montorsi F, Andersson KE, Stief CG. Phosphodiesterase inhibitors for the treatment of erectile dysfunction. Curr Opin Investig Drugs. 2002 Oct; 3(10):1489-95. PMID: 12431025.
      View in: PubMed
    295. Pandita RK, Andersson KE. Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J Urol. 2002 Sep; 168(3):1230-4. PMID: 12187273.
      View in: PubMed
    296. Kaidoh K, Igawa Y, Takeda H, Yamazaki Y, Akahane S, Miyata H, Ajisawa Y, Nishizawa O, Andersson KE. Effects of selective beta2 and beta3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol. 2002 Sep; 168(3):1247-52. PMID: 12187276.
      View in: PubMed
    297. Mizusawa H, Hedlund P, Sjunnesson J, Brioni JD, Sullivan JP, Andersson KE. Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist. Br J Pharmacol. 2002 Jul; 136(5):701-8. PMID: 12086979; PMCID: PMC1573401.
    298. Andersson KE. Treatment of the overactive bladder: possible central nervous system drug targets. Urology. 2002 May; 59(5 Suppl 1):18-24. PMID: 12007518.
      View in: PubMed
    299. Pehrson R, Andersson KE. Effects of tiagabine, a gamma-aminobutyric acid re-uptake inhibitor, on normal rat bladder function. J Urol. 2002 May; 167(5):2241-6. PMID: 11956486.
      View in: PubMed
    300. Andersson KE. Bladder activation: afferent mechanisms. Urology. 2002 May; 59(5 Suppl 1):43-50. PMID: 12007522.
      View in: PubMed
    301. Andersson KE, Chapple CR, Höfner K. Future drugs for the treatment of benign prostatic hyperplasia. World J Urol. 2002 Apr; 19(6):436-42. PMID: 12022712.
      View in: PubMed
    302. Gu BJ, Ishizuka O, Igawa Y, Nishizawa O, Andersson KE. Role of supraspinal alpha1-adrenoceptors for voiding in conscious rats with and without bladder outlet obstruction. J Urol. 2002 Apr; 167(4):1887-91. PMID: 11912454.
      View in: PubMed
    303. Schroder A, Hedlund P, Andersson KE. Carbon monoxide relaxes the female pig urethra as effectively as nitric oxide in the presence of YC-1. J Urol. 2002 Apr; 167(4):1892-6. PMID: 11912455.
      View in: PubMed
    304. Andersson KE. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol. 2002 Apr; 19(6):390-6. PMID: 12022707.
      View in: PubMed
    305. Chapple C, Andersson KE. Tamsulosin: an overview. World J Urol. 2002 Apr; 19(6):397-404. PMID: 12022708.
      View in: PubMed
    306. Andersson KE. a-Adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with a-adrenoceptor antagonists. World J Urol. 2002 Apr; 19(6):390-396. PMID: 28386659.
      View in: PubMed
    307. Mizusawa H, Hedlund P, Andersson KE. alpha-Melanocyte stimulating hormone and oxytocin induced penile erections, and intracavernous pressure increases in the rat. J Urol. 2002 Feb; 167(2 Pt 1):757-60. PMID: 11792967.
      View in: PubMed
    308. Ishizuka O, Gu B, Igawa Y, Nishizawa O, Pehrson R, Andersson KE. Role of supraspinal serotonin receptors for micturition in normal conscious rats. Neurourol Urodyn. 2002; 21(3):225-30. PMID: 11948716.
      View in: PubMed
    309. Takeda H, Yamazaki Y, Igawa Y, Kaidoh K, Akahane S, Miyata H, Nishizawa O, Akahane M, Andersson KE. Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn. 2002; 21(6):558-65. PMID: 12382247.
      View in: PubMed
    Andersson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _